CLEO Diagnostics kicks off IP transfer for ovarian cancer blood tests to US manufacturers
CLEO Diagnostics (ASX:COV), a company developing a simple blood test for ovarian…
Cleo Diagnostics Ltd (ASX:COV)
About Cleo Diagnostics Ltd
Key Information
COV In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 09.09am 28/04/2025 | Price Sensitive PS CLEO to Fast Track Development of Ovarian Cancer Test | 522.41KB | 168 |
| 24/04/2025 | Notification regarding unquoted securities - COV | 20.62KB | 175 |
| 24/04/2025 | Price Sensitive PS CLEO Receives A$845k Research and Development Tax Incentive | 473.54KB | 187 |
| 11/04/2025 | Price Sensitive PS Quarterly activities and cashflow report | 751.94KB | 1.7K |
| 18/03/2025 | Price Sensitive PS CLEO Delivers Commercial Development Milestone | 511.71KB | 954 |
| 27/02/2025 | Price Sensitive PS Appendix 4D and Half Yearly Accounts | 596.53KB | 400 |
| 17/02/2025 | Clarification to ASX Price Query | 461.92KB | 2.7K |
| 07/02/2025 | Price Sensitive PS Price Query Response | 889.55KB | 5.3K |